FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109593104> ?p ?o ?g. }

• W2109593104 endingPage "609" @default.
• W2109593104 startingPage "599" @default.
• W2109593104 abstract "We dissected the T cell activation potency and the immunoglobulin (Ig) E-binding properties (allergenicity) of nine isoforms of Bet v 1 (Bet v 1a-Bet v 1l), the major birch pollen allergen. Immunoblot experiments showed that Bet v 1 isoforms differ in their ability to bind IgE from birch pollen-allergic patients. All patients tested displayed similar IgE-binding patterns toward each particular isoform. Based on these experiments, we grouped Bet v 1 isoforms in three classes: molecules with high IgE-binding activity (isoforms a, e, and j), intermediate IgE-binding (isoforms b, c, and f), and low/no IgE-binding activity (isoforms d, g, and 1). Bet v 1a, a recombinant isoform selected from a cDNA expression library using IgE immunoscreening exhibited the highest IgE-binding activity. Isoforms a, b, d, e, and 1 were chosen as representatives from the three classes for experimentation. The potency of each isoallergen to activate T lymphocytes from birch pollen-allergic patients was assayed using peripheral blood mononuclear cells, allergen-specific T cell lines, and peptide-mapped allergen-specific T cell clones. Among the patients, some displayed a broad range of T cell-recognition patterns for Bet v 1 isoforms whereas others seemed to be restricted to particular isoforms. In spite of this variability, the highest scores for T cell proliferative responses were observed with isoform d (low IgE binder), followed by b, 1, e, and a. In vivo (skin prick) tests showed that the potency of isoforms d and 1 to induce typical urticarial type 1 reactions in Bet v 1-allergic individuals was significantly lower than for isoforms a, b, and e. Taken together, our results indicate that hypoallergenic Bet v 1 isoforms are potent activators of allergen-specific T lymphocytes, and Bet v 1 isoforms with high in vitro IgE-binding activity and in vivo allergenicity can display low T cell antigenicity. Based on these findings, we propose a novel approach for immunotherapy of type I allergies: a treatment with high doses of hypoallergenic isoforms or recombinant variants of atopic allergens. We proceed on the assumption that this measure would modulate the quality of the T helper cell response to allergens in vivo. The therapy form would additionally implicate a reduced risk of anaphylactic side effects." @default.
• W2109593104 created "2016-06-24" @default.
• W2109593104 creator A5001947716 @default.
• W2109593104 creator A5005096039 @default.
• W2109593104 creator A5006758370 @default.
• W2109593104 creator A5010955441 @default.
• W2109593104 creator A5021851371 @default.
• W2109593104 creator A5038864235 @default.
• W2109593104 creator A5040611651 @default.
• W2109593104 creator A5041577601 @default.
• W2109593104 creator A5050310993 @default.
• W2109593104 creator A5070127639 @default.
• W2109593104 creator A5080815818 @default.
• W2109593104 creator A5087622620 @default.
• W2109593104 date "1996-02-01" @default.
• W2109593104 modified "2023-10-11" @default.
• W2109593104 title "Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy." @default.
• W2109593104 cites W124547280 @default.
• W2109593104 cites W1480346494 @default.
• W2109593104 cites W1481619148 @default.
• W2109593104 cites W1484235628 @default.
• W2109593104 cites W1488757445 @default.
• W2109593104 cites W1488976619 @default.
• W2109593104 cites W1491481694 @default.
• W2109593104 cites W1526374445 @default.
• W2109593104 cites W1531177247 @default.
• W2109593104 cites W1544152039 @default.
• W2109593104 cites W1582598578 @default.
• W2109593104 cites W1600727079 @default.
• W2109593104 cites W1668142298 @default.
• W2109593104 cites W1679527748 @default.
• W2109593104 cites W1873199501 @default.
• W2109593104 cites W1925788296 @default.
• W2109593104 cites W1976176385 @default.
• W2109593104 cites W1990197546 @default.
• W2109593104 cites W2003902333 @default.
• W2109593104 cites W2018289835 @default.
• W2109593104 cites W2022708664 @default.
• W2109593104 cites W2034277352 @default.
• W2109593104 cites W2036185162 @default.
• W2109593104 cites W2042381017 @default.
• W2109593104 cites W2049465161 @default.
• W2109593104 cites W2055773200 @default.
• W2109593104 cites W2067118713 @default.
• W2109593104 cites W2084571894 @default.
• W2109593104 cites W2089339054 @default.
• W2109593104 cites W2089657316 @default.
• W2109593104 cites W2091261717 @default.
• W2109593104 cites W2093740248 @default.
• W2109593104 cites W2100837269 @default.
• W2109593104 cites W2101108802 @default.
• W2109593104 cites W2103903862 @default.
• W2109593104 cites W2111583006 @default.
• W2109593104 cites W2120012263 @default.
• W2109593104 cites W2130886030 @default.
• W2109593104 cites W2134514926 @default.
• W2109593104 cites W2138270253 @default.
• W2109593104 cites W2155750360 @default.
• W2109593104 cites W2158860741 @default.
• W2109593104 cites W2162379251 @default.
• W2109593104 cites W2163037816 @default.
• W2109593104 cites W2164025040 @default.
• W2109593104 cites W2165029064 @default.
• W2109593104 cites W2171444394 @default.
• W2109593104 cites W2172466148 @default.
• W2109593104 cites W2176716563 @default.
• W2109593104 doi "https://doi.org/10.1084/jem.183.2.599" @default.
• W2109593104 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2192443" @default.
• W2109593104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8627171" @default.
• W2109593104 hasPublicationYear "1996" @default.
• W2109593104 type Work @default.
• W2109593104 sameAs 2109593104 @default.
• W2109593104 citedByCount "291" @default.
• W2109593104 countsByYear W21095931042012 @default.
• W2109593104 countsByYear W21095931042013 @default.
• W2109593104 countsByYear W21095931042014 @default.
• W2109593104 countsByYear W21095931042015 @default.
• W2109593104 countsByYear W21095931042016 @default.
• W2109593104 countsByYear W21095931042017 @default.
• W2109593104 countsByYear W21095931042018 @default.
• W2109593104 countsByYear W21095931042019 @default.
• W2109593104 countsByYear W21095931042020 @default.
• W2109593104 countsByYear W21095931042021 @default.
• W2109593104 countsByYear W21095931042022 @default.
• W2109593104 countsByYear W21095931042023 @default.
• W2109593104 crossrefType "journal-article" @default.
• W2109593104 hasAuthorship W2109593104A5001947716 @default.
• W2109593104 hasAuthorship W2109593104A5005096039 @default.
• W2109593104 hasAuthorship W2109593104A5006758370 @default.
• W2109593104 hasAuthorship W2109593104A5010955441 @default.
• W2109593104 hasAuthorship W2109593104A5021851371 @default.
• W2109593104 hasAuthorship W2109593104A5038864235 @default.
• W2109593104 hasAuthorship W2109593104A5040611651 @default.
• W2109593104 hasAuthorship W2109593104A5041577601 @default.
• W2109593104 hasAuthorship W2109593104A5050310993 @default.
• W2109593104 hasAuthorship W2109593104A5070127639 @default.
• W2109593104 hasAuthorship W2109593104A5080815818 @default.
• W2109593104 hasAuthorship W2109593104A5087622620 @default.

• next